United States - Healthcare - D.C. Circuit Becomes Second Federal Appeals Court To Allow Restrictions On 340B Contract Pharmacies
On May 21, the U.S. Court of Appeals for the D.C. Circuit issued a unanimous decision in favor of drug manufacturers, finding that certain manufacturer restrictions on the use of contract...
Source: mondaq.com